Month: June 2017

Penny Pick Finders Review Trading Penny Stocks

Penny Pick Finders ReviewThe stock market is a scary place for many investors this Halloween, but it isn’t because of spooky costumes or wicked sounds emanating from a haunted house. It is the frightening state of the economy which has kept many would-be-investors running with their hands up. Instead of panicking and throwing in the towel completely, when it comes to investing, why not try making a serious killing in cash with penny stock investing by utilizingPenny Pick Finders, a penny stock newsletter than gives you well researched penny stock picks every week that other investors may not be paying much attention to. So lts start with my Penny Pick Finders review:

How Does This Program Help You To Make Money?

It is time to change the way we invest. The old, buy and hold routine used to work really well for people, and maybe even some investors can still make money like this. The top 1% is still getting richer, so shouldn’t you be able to join their ranks? Penny Pick Finders sends a weekly newsletter that is full of well-documented companies that are still in their infancy. These companies have great CEOs. They have great income. They are selling their products like hot cakes and they are poised to take off to become the next big thing.

Can you imagine investing in Google in its infancy, or Facebook? What about Yahoo or a million other companies, that were once just like these penny stocks, trying to make it in the big world, but having to start from ground zero, like every other company out there. Penny Pick Finders is one of the best penny stock newsletters out there and this is why I wrote this Penny Stock Finders Review.

The bottom line is that the makers of the Penny Pick Finders newsletter are well versed at spotting companies that are very likely to be future winners. Some penny stocks can earn you as much as 1000% profit in a matter of hours when you get in and out at the right time. This newsletter will show you strategies for maximizing losses and minimizing gains, utilizing some of the best kept secrets in the market – penny stocks for companies that are showing great sales and revenue, companies that are outperforming others in their sector, and companies that are breaking earnings records and have sound management.

Some Examples Of Profits Some Of The Many Penny Pick Finders Customers Made:

pennypickfinders

They Focus On Solid Penny Stocks!

These are the true qualities of a winning company, not some drummed up hype that might make a temporary fluctuation in stock price. Even though you can still earn money on even those fluctuations, you can earn even bigger still on quality companies growing out of their infancy and into a full-fledged power house right before your eyes. The trick is getting in on these stocks while they are young, but just before they take off.

Get Well Researched Stock Picks

Penny Pick Finders will send you a sound, well-researched, easy-to-read scenario of possible stock picks with quality information so that you can make a well-educated investment. Stop throwing your money away on penny stocks that you hope will one day make it big. Half of them are never going to get out of the infancy stage. Instead, use this newsletter to make well-informed decisions on investing in penny stocks that are about to go big or go home.

The Guys Behind Penny Pick Finders Are Pros And The Program Is NOT A Scam!

Small cap and micro cap investing can be daunting. There are so many different companies to choose from. You could spend months going over fundamentals for just one company, but you don’t need to do that anymore. The writers of the www.pennypickfinders.com newsletter are industry savvy investors who know what to look for and report back to you, their findings. Get a play-by-play stock profile on each stock, as well as pattern and performance updates.

Conclusion

Start with as little as $200 and see what penny stock investing can do for you. As with all investing – it is wise to do your own comparative research before purchasing any stock. With the information gained from reading the Penny Pick Finders newsletter, you can invest a small amount of money to make some possibly huge returns. As you can see our Penny Pick Finders Review is definitely POSITIVE. We definitely recommend Penny Pick Finders newsletter.

subscribe to penny picks finders

Read More

Penny Stock Promotion

Arch Therapeutics Inc (ARTH.OB)

About Us
Arch Therapeutics, Inc. (Arch), in the past Almah, Inc occupied with creating polymers containing peptides proposed to shape gel-like obstructions over injuries to stop or control draining and seal wounds. The Company is a restorative gadget organization offering an exquisite and better approach than the quick discontinuance of dying (hemostasis) and control of liquid spillage (sealant) amid surgery and injury care. The Company items that incorporate the AC5 is utilized for control over surgical dying. AC5 is an engineered peptide comprising actually happening amino acids. Confirmation to-date bolsters that it is biocompatible. AC5 is connected specifically onto a surgical or traumatic injury, where it quickly makes a physical boundary in the alcoves and crevices of the tissue and instantly quits draining and liquid holes.
AC5 is a manufactured peptide comprising actually happening amino acids. Proof to-date underpins that it is biocompatible. At the point when squirted or showered onto an injury, AC5 speedily intercalates into the niches and crevices of the connective tissue where it incorporates itself with a physical, mechanical structure. That structure gives a boundary to releasing substances, including blood and other natural liquids, paying little respect to kind of surgery or, in view of right on time information, thickening capacity. Recuperating happens typically.
Recent news
Curve Therapeutics, Inc. (OTCQB: ARTH) (Arch or the Organization), on June 9th, 2015 announced that the company who the engineer of the AC5 Surgical Hemostatic Device™ (AC5™), got information from a preclinical danger test for AC5™ that demonstrate the gadget was all around endured and named not poisonous in a state sanctioned test of systemic harmfulness. The systemic poisonous quality creature test is a noteworthy part of the biocompatibility test board that a medicinal gadget should ordinarily finish effectively preceding use in the humans.
The company on july, 1st 2015 made another announcement that it is happy to declare that it brought $3,066,000 up in value financing in a private arrangement to 19 licensed speculators (the Speculators) on June 30, 2015 (the Starting Closing), and envisions raising up to an extra $100,000 before finishing up the private position (the 2015 Private Placement Financing). At the Initial Closing, the Company sold and the Investors obtained 13,936,367 Units at a price tag of $0.22 per Unit. Every Unit comprised of an offer of the Companys normal stock, standard quality $0.001 per offer (Common Stock), and a Series D Warrant to buy an offer of Common Stock at an activity cost of $0.25 per offer whenever before the fifth commemoration of the issuance date of the Series D Warrant.
Officers and directors
Avtar S. Dhillon M.D.

Chairman of the Board
Terrence W. Norchi M.D.

President, Chief Executive Officer, Director
Richard E. Davis

Chief Financial Officer, Treasurer
Coates International Ltd (COTE.PK)
About Us
Coates International, Ltd. (CIL) is precision engineering organization. The Company creates advancements that develop the standard ignition motor. The Companys coates circular revolving valve (CSRV) framework innovation is versatile for utilization in cylinder driven inward ignition motors of numerous sorts. The CSRV framework innovation is intended to supplant the admission and fumes traditional poppet valves utilized as a part of all cylinder driven, car, truck, cruiser, marine and electric force generator motors, among others. The Company has built up two regular gas fueled CSRV frameworks, the C86GE motor and the C86GG generator, principally with the end goal of on location, mechanical evaluation power era. The C86GE motor is a segment of the C86GG power generator. The C86GG is a completely coordinated normal gas power generator for on location electrical force era.
Recent news
On July 21st, 2015 Stephen Hicks, Chairman and CEO of Southridge Capital, reported that Southridge Partners II LP (Southridge), an institutional speculator, went into a value buy concurrence with COATES (OTC Pink: COTE), an accuracy designing organization situated in New Jersey. The amount obtained from this value purchase understanding will be utilized to reserve fabricating operations which are as of now in progress on a restricted scale and for general working capital purposes. In a press discharge put out by the COATES, George J. Coates, President and CEO, expressed, The stores will be gotten to at our sole alternative, which should be in view of timing controlled by our administration, with the goal of accomplishing our strategy for success.
The administration of the Company is respected to have Mr. Jack Perkowski join our governing body and serve as the new Chairperson of our Audit Committee, as cited in the company’s press release on February 17, 2015.
Officers and directors
George J. Coates

Chairman of the Board, President, Chief Executive Officer
Barry C. Kaye

Chief Financial Officer, Treasurer, Director
Gregory G. Coates

Director, Secretary and President, Technology Division

Total Views: 31 ,

Read More

Penny Stock Promotion

oxis-biotech-logo

Introduction

If you happened to see many a “Bull” among the small and micro cap stock traders this week at the OTC market, you must have surely recognized iHookup(OTC:HKUP) by now. The stock price yield of 150% observed on 17th of June (is it July? /correction) could have been due to recent company updates; or a couple of investor awareness campaigns carried out by the company. Here we present a few things to see, which could reveal the pertinent factors visibly to you about the company and its remarkable Bullish run.
Body Text

With a rapidly growing volume of 10.3 million and 30-d Average of 7.8 million, iHookup seems to have created an impression of overbought penny stocks. The growth from its 52-Week low of 0.0007 to touch $5 on June 19th makes it 1200%.

Probability number 1:-

One possible reason could be the increase in its Mobile-App downloads. On 17th June, iHookup put up a press release.

Excerpts from Press Release
Team iHookup (OTC: HKUP), with its young entrepreneurs and developers is pleased to announce that it is well equipped to enter the next phase of business growth. Company sources said that its consistent bullish run in stock market and reducing numbers of debt-holders helps focus on future. The company is concentrating on its release of “friendable brand to the Apple App Store in July of 2015.
Robert Rositano Jr., CEO, iHookup Social thanked all the funding-partners for helping to create a launch-pad in the US markets through its downloadable Apps.

Probability number 2:-

This could be the constant flood of emails, which have virtually inundated our mailbox about the stock from paid investor awareness programs. Currently HKUP has a buying rate of 40% in the market.
Brief Company Profile
Company iHookup designs, develops and delivers mobile apps for connecting people across various walks of social, corporate and business worlds. Its customers have immensely benefited with the apps’ “timing and proximity optimization” features. They gratify users’ aspiration to find “like-minded” and “likable” friends within their “mobility” regions and their preferred timings. This is perhaps the best “edge” given by its apps to its customers, stakeholders as well as its own “growth and expansion”.
Conclusion
We would like to sum up the whole set of stock market and consumer equations with something like; iHookup seems to be “in line” with evolving aspects socializing and dating aspirations of every generation today. This could become a future synonym for customers’ lifestyle and investors’ money plant, depending on the consumer’s buying trends.

Total Views: 24 ,

Read More

Penny Stock Promotion

https://www.youtube.com/watch?v=gezBQM8FTnE

Anavex Life Sciences Corp., is a clinical-stage biopharmaceutical organization occupied with the advancement of medication hopefuls. The Companys lead mixes incorporate ANAVEX 2-73, ANAVEX PLUS, a mix of ANAVEX 2-73 with donepezil (Aricept), ANAVEX 19-144, ANAVEX 1-41, ANAVEX 7-1037, ANAVEX 3-71, ANAVEX 1079, ANAVEX 1519 and ANAVEX 1066 being produced to treat Alzheimers malady and other focal sensory system (CNS) ailments. The Companys SIGMACEPTOR Discovery Platform created little atom medication competitors with special methods of activity. Sigma receptors may be focuses for therapeutics to battle numerous human ailments, including Alzheimers malady. At the point when bound by the proper ligands, sigma receptors impact the working of various biochemical signs that are included in the pathogenesis (inception or advancement) of ailment.

ANAVEX company logo

ANAVEX 2-73, the Companys orally accessible medication competitor created to treat Alzheimers through potential ailment alteration, has experienced a beginning Phase 1 human clinical trial and was all around endured in dosages up to 55mg. Results from pre-clinical studies show that ANAVEX 2-73 exhibits against amnesic and neuroprotective properties.

An exceptionally reassuring synergistic impact has additionally been seen between ANAVEX 2-73 and donepezil (Aricept®). The consolidated therapeutics, alluded to as ANAVEX PLUS, created up to 80% more noteworthy inversion of memory misfortune in Alzheimers malady models versus when the medications were utilized independently.

ANAVEX PLUS is accepted to be a convincing business opportunity. The clinical trial danger is lower in light of the fact that donepezil (Aricept®) is as of now available, with worldwide offers of $4-billion every year. Donepezil (Aricept®) is presently non specific and a patent application has been petitioned for ANAVEX PLUS which, if in truth, would give assurance until 2033.

There was one organization said cnafinance.com in one of its most recent reports on biotech stock news on 28th July, 2015 that performed a little study however acquired better results in patients with Alzheimers. This organization is known as Anavex Life Sciences Corp. (OTCMKTS:AVXL) and they discharged positive stage 2a outcomes in their Alzheimers trial.

This stage 2a trial is enlisting 32 patients’ altogether, yet the outcomes just originate from the initial 12 patients. No less than 10 out of 12 patients accomplished positive psychological impacts for their Alzheimers — means around 83% of the patients. All the more particularly those patients taking Anavexs medication Anavex 2-73 saw a 38% change from gauge. A 38% expansion from gauge is four times more prominent than donepezil — showcased under the name Aricept — which is the present standard of administer to Alzheimers patients.

Remember however that this was just the initial 12 patients of the study so the information is little and preparatory in nature. In spite of that however in the event that Anavex discharges the full stage 2a outcomes at a later time point and are the same as these outcomes then this will keep on taking off to a higher of price of their shares in the market.

Officers and directors

Christopher U. Missling Ph.D. President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary, Director
Elliot J. Favus M.D. Director
Bernd Metzner Ph.D. Director
Athanasios Skarpelos Director
Steffen Thomas PhD Director

Total Views: 29 ,

Read More

Penny Stock Promotion

EP Global Communications Inc (EPGL.PK)
About Us
EP Global Communications, Inc. is a biomedical gadget assembling and showcasing organization. The company is centered on creating and advertising restorative gadgets for both determination and treatment of constant torment. The Company is as of now attempting to imagine and create extra restorative gadget innovation items to acquaint with the MPDD, which is a torment administration gadget, including biomedical gadgets which use Bio-Micro-Electro Mechanical Systems innovation (Bio-MEMS).
The MPDD gadget is a created clinical and mechanical stage for diagnosing muscle torment. The MPDD has gotten FDA 510K freedom for promoting and assembling. The essential business for MPDD will be torment administration doctors and essential consideration doctors later growing to games pharmaceutical and physical advisors. MPDD will empower the doctors to understand the full estimation of symptomatic devices, for example, MRI, CT check, X-beam standard physical examination. MPDD consolidates two advancements. The primary is a symptomatic technique. The licensed variant of this system takes into consideration the determination of muscles in a dynamic, normal, state (instead of static). This component builds the exactness of the conclusion while the one of a kind technique gives seclusion of the torment generator, expanding precision. The MPDD gadget fuses innovation for trans-cutaneous-electroneural incitement, for animating muscle.


Recent news
Though the ticker during the first part of 2015 was hovering around $0.050 per share mark for about sometime but the value has been now rising slowly. This may be due to the company’s announcement last Thursday stating that in concern to its electronic contact lens technology the company has planned to initiate its discussions with Novartis AG (NYSE: NVS).
In another material improvement to shareholders, EPGL wired news on March 30th 2015 that it has opened transactions with Cooper Vision, Inc. at $1.1 billion for the restrictive Option to License their new ophthalmic advancements. As beforehand unveiled freely, Cooper Vision, Inc. also, EP Global Communications, Inc. have co-grew new contact lens innovations, which has prompted a few new patent filings. It is evaluated by some industry specialists that only one of these recently created innovations could add $5 billion yearly to contact lens deals around the world.
Officers and directors
Michael Hayes

President
Corey W. Hunter M.D.

Medical Director and Chairman of the Scientific Advisory Board

Total Views: 35 ,

Read More

Our New Pick Is Hawker Energy (HWKR)

Good Morning Traders,

After our huge success on winners for facebook followers, we are here again to reward you with our Special pick.

You already Know The Deal So Take Action NOW and do what you must Before The Big Boys. My New Pick is Hawker Energy Inc (OTCBB:HWKR)

If you are still reading right now and have NOT taken action you could be making a huge mistake as HWKR is probably ripping out the gate from it’s open at .09 cents on it’s way to possibly being the #1 Overall Market Gainer Today.

Are you STILL reading without taking action? You very well might have left a double on the table.

This pick has a MICRO Float and an interesting story.

Email often get’s delayed so you should be VERY happy you signed up for our SMS List where you get the Ultimate Edge!

Here are the Goods on HWKR

Hawker Energy (OTC: HWKR) focuses on the acquisition and development of mature land leases, interests and other rights to oil and gas properties. HWKR’s goal is to deliver long-term value to its shareholders through financial discipline, opportunistic acquisition and efficient operation. To do so, HWKR is focused on the following objectives:

Acquisition of producing assets with low-risk proven development potential.

Maximization of value through operational efficiency and technical expertise.

Optimization of oil recovery using proven technologies.

MANAGEMENT HIGHLIGHTS

Darren Katic, Chairman and Co-Chief Executive Officer

Has personally raised over $600 million in capital for oil projects in North America.

Has held various senior management positions in the oil and gas industry

Grew Pacific Energy’s over 10,000 barrels per day with over $300 million in annual revenues.

Charles Moore, Co-Chief Executive Officer

12 years of experience building and restructuring companies to achieve high levels of operational efficiency and returns on invested capital.
Has acted as CFO of four companies, three of which were sold to larger strategic buyers in various industries.

Has been a general partner of two private equity firms – UBS Capital Americas (1998-2002) and Jacobson Partners (2004-2009), and focused on operationally challenged companies.

Gerry Tywoniuk, Executive Vice President and Chief Financial Officer

From 2010 to the present, Mr. Tywoniuk has provided project CFO services to several companies.

Currently serves as a director and audit committee chairman on the boards of the general partner of two public companies: American Midstream Partners, LP (NYSE:AMID)(natural gas midstream) and Oxford Resource Partners, LP (NYSE:OXF)(coal mining).

Was Senior Vice President and CFO of Pacific Energy Partners, LP. and refined products transportation and storage), and Senior Vice President and CFO, MarkWest Energy Partners, L.P. and predecessor (natural gas midstream).

Harry Barnum, Chief Operating Officer

Has more than 20 years oil industry experience including 6 years with Chevron.

While with Windsor Energy Corporation, Mr. Barnum was responsible for all activities at the field, which achieved peek production of over 2,000 barrels per day

Currently Mr. Barnum is Manager TEG Oil USA, and has been responsible for the re-development of the Tapia Oil Field.

PROPERTIES OVERVIEW

HWKR’s operations currently include the following projects:

Eureka – Eureka Canyon Oilfield is located approximately 20 miles west of Tapia Canyon Oil Field, in Ventura County, California. Eureka has been producing since its discovery in 1893. Over time, the field has been produced an estimated cumulative oil production of approximately 1,200,000 barrels, or over $90 million, of oil. The lease is composed of approximately 1,550 gross acres, with about 50 acres in the western portion of the lease known productive at this time.

PRC – The PRC 145.1 lease contains 341 acres and has been previously tested with a total of 14 wells. A single active well on PRC 145.1 has historically produced an average of 10 barrels of oil per day.

Rincon – The Rincon Oilfield is a large oil field on the coast of southern California, about ten miles northwest of the city of Ventura, and about 20 miles east-southeast of the city of Santa Barbara. Rincon is ranked 36th in California by size of recoverable oil reserves.

Tapia – Originally founded by Texaco, the Tapia Canyon field covers an area of approximately 280 acres located about 40 miles north of the Los Angeles metropolitan area.

Last but certainly not least is HWKR’s prize property located within the Midway-Sunset oil field, which is one of the top 10 producing oil fields in the United States. In fact, petroleum giants such as Shell and ExxonMobil are drilling in the same vicinity as HWKR’s “DEEP” lease, which consists of 40 acres of land in a famously rich area of California.

Midway-Sunset is the largest oil field in California and the third largest in the United States. To date, historical production of this area is estimated at over 3 billion barrels of oil. At current prices, that means this oil field’s 11,000 plus producing wells have already produced over $200 billion worth of oil product.

Aera Energy, which is jointly owned by Shell and ExxonMobil, owns property within the Midway-Sunset oil field, which accounts for 25% of California’s oil production. The estimated daily production of Aera’s Midway-Sunset properties is 24,000 barrels, or roughly $2 million, of oil equivalent. This would put potential revenues from Aera’s Midway-Sunset operations over $700 million annually. With figures like these, there is no wonder why Aera has become the sixth largest oil operator in the Unites States.

So, you mean to tell me that HWKR holds an interest in various properties including a 40-acre lease of land in an oil field historically known to have produced billions of dollars worth of oil? YES! As of market close November 11th, price per share was $0.09. At this price point, petroleum giants like Shell and ExxonMobil won’t be the only ones watching HWKR like a hawk.

Happy Trading,
SpecialPennyStockAlert Team

Important Notice & Disclaimer

*Never invest in a stock mentioned by Specialpennystockalert.com unless you can afford to lose your entire investment.

Release of Liability: Through use of this website viewing or using you agree to hold Specialpennystockalert.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may suffer. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Specialpennystockalert.com’s employees do not own any shares of the mentioned company(s). Specialpennystockalert.com will also disclose any compensation. Specialpennystockalert.com has been compensated upto four thousand dollars for marketing efforts regarding HWKR.

Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. Specialpennystockalert.com encourages readers and investors to supplement the information in this report with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Specialpennystockalert.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Specialpennystockalert.com, nor any of its affiliates are not registered investment advisors or a broker dealers.

Read More

My New Pick Is Axxess Pharma, Inc. (AXXE)

Special Penny Members,

I need you all to FOCUS and Need Your FULL Attention:

Tomorrow’s Wild Wednesday Alert is: Axxess Pharma, Inc. (AXXE)

Something is brewing I just feel it in my bones, something that you MUST not overlook.

You need to be liquid and you need to be ready because if you miss this one you might as well hang up your monitors for good, because you might never forgive yourselves.

AXXE has a history of tremendous, volatile and lucrative moves. In fact many members say that AXXE has been one of their favorite companies to trade over the past 6 months. 

So as you can see, Axxess Pharma, Inc. is a company loved by many and with an array of positive news and developments that have come out over the past month, it is an alert that can just not be missed.

Check Out These Recent Developments For Yourself:

-Feb 12th 2015 Axxess Pharma Expands Global Sales Into Asia
http://finance.yahoo.com/news/axxess-pharma-expands-global-sales-130000774.html

-March 4th, 2015 Axxess Pharma Receives Initial Purchase Order From Australian Distributor Hardcore Beverages http://finance.yahoo.com/news/axxess-pharma-receives-initial-purchase-130000708.html

-March 16th, 2015 (was the kicker and catalyst moving forward in our opinion)
Axxess Pharma Receives US FDA Approval to Sell Omega-3 Fish Oil, Muscle Growth, Muscle Recovery Supplements and Turbo Blend Protein Powder

Take the above news and add the fact that AXXE Management Projecting $2.5 Million in Year over Year Sales and that imo opinion is high probability for a winning cocktail in the near term.

I do not put out price targets I wouldn’t be surprised to see AXXE rapidly appreciate from its current undervalued levels as soon as tomorrow and throughout next week (in my opinion).

The materials are prepared, smart money is prepared, so the only remaining question is:

Will YOU Be?

Happy Trading,
SpecialPennyStockAlert Team

Important Notice & Disclaimer

*Never invest in a stock mentioned by Specialpennystockalert.com unless you can afford to lose your entire investment.

Release of Liability: Through use of this website viewing or using you agree to hold Specialpennystockalert.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may suffer. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. Specialpennystockalert.com’s employees do not own any shares of the mentioned company(s). Specialpennystockalert.com will also disclose any compensation. Specialpennystockalert.com has been compensated up to eight thousand five hundred Cash from a Non Controlling 3rd Party.

Our emails may contain forward looking statements, which are not guaranteed to materialize due to a variety of factors. We do not guarantee the timeliness, accuracy, or completeness of the information on our site or in our newsletters. The information in our email newsletters and on our website is believed to be accurate and correct, but has not been independently verified and is not guaranteed to be correct. Specialpennystockalert.com encourages readers and investors to supplement the information in this report with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and Specialpennystockalert.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Specialpennystockalert.com, nor any of its affiliates are not registered investment advisors or a broker dealers.

Read More